Match!

Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: Regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans

Published on Mar 1, 2007in Human Mutation4.453
· DOI :10.1002/humu.20429
Joan C. Marini42
Estimated H-index: 42
(NIH: National Institutes of Health),
Antonella Forlino29
Estimated H-index: 29
(UNIPV: University of Pavia)
+ 24 AuthorsPeter H. Byers70
Estimated H-index: 70
(UW: University of Washington)
Abstract
Osteogenesis imperfecta (OI) is a generalized disorder of connective tissue characterized by fragile bones and easy susceptibility to fracture. Most cases of OI are caused by mutations in type I collagen. We have identified and assembled structural mutations in type I collagen genes (COL1A1 and COL1A2, encoding the proα1(I) and proα2(I) chains, respectively) that result in OI. Quantitative defects causing type I OI were not included. Of these 832 independent mutations, 682 result in substitution for glycine residues in the triple helical domain of the encoded protein and 150 alter splice sites. Distinct genotype–phenotype relationships emerge for each chain. One-third of the mutations that result in glycine substitutions in α1(I) are lethal, especially when the substituting residues are charged or have a branched side chain. Substitutions in the first 200 residues are nonlethal and have variable outcome thereafter, unrelated to folding or helix stability domains. Two exclusively lethal regions (helix positions 691–823 and 910–964) align with major ligand binding regions (MLBRs), suggesting crucial interactions of collagen monomers or fibrils with integrins, matrix metalloproteinases (MMPs), fibronectin, and cartilage oligomeric matrix protein (COMP). Mutations in COL1A2 are predominantly nonlethal (80%). Lethal substitutions are located in eight regularly spaced clusters along the chain, supporting a regional model. The lethal regions align with proteoglycan binding sites along the fibril, suggesting a role in fibril–matrix interactions. Recurrences at the same site in α2(I) are generally concordant for outcome, unlike α1(I). Splice site mutations comprise 20% of helical mutations identified in OI patients, and may lead to exon skipping, intron inclusion, or the activation of cryptic splice sites. Splice site mutations in COL1A1 are rarely lethal; they often lead to frameshifts and the mild type I phenotype. In α2(I), lethal exon skipping events are located in the carboxyl half of the chain. Our data on genotype–phenotype relationships indicate that the two collagen chains play very different roles in matrix integrity and that phenotype depends on intracellular and extracellular events.
  • References (67)
  • Citations (410)
📖 Papers frequently viewed together
182 Citations
200636.22Cell
20 Authors (Roy Morello, ..., Brendan Lee)
347 Citations
309 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References67
Newest
#1Darwin J. Prockop (Thomas Jefferson University)H-Index: 120
#2Alain Colige (Thomas Jefferson University)H-Index: 1
Last. Philipp Vandenberg (Thomas Jefferson University)H-Index: 5
view all 6 authors...
Work by a large number of investigators over the last decade has established that over 90% of the patients with osteogenesis imperfecta have mutations in one of the two genes for type I procollagen, that most unrelated probands have different mutations in the genes, and that the mutations found in most of the serious variants of the disease cause synthesis of abnormal proα chains of the protein. The results have demonstrated that synthesis of structurally abnormal but partially functional proα c...
41 CitationsSource
#1Fransiska Malfait (Ghent University Hospital)H-Index: 35
#2Sofie Symoens (Ghent University Hospital)H-Index: 22
Last. A. De Paepe (Ghent University Hospital)H-Index: 81
view all 6 authors...
Background: Heterozygous mutations in the COL1A1 or COL1A2 gene encoding the α1 and α2 chain of type I collagen generally cause either osteogenesis imperfecta or the arthrochalasis form of Ehlers-Danlos syndrome (EDS). Homozygous or compound heterozygous COL1A2 mutations resulting in complete deficiency of the proα2(I) collagen chains are extremely rare and have been reported in only a few patients, albeit with variable phenotypic outcome. Methods: The clinical features of the proband, a 6 year ...
73 CitationsSource
#1Wayne A. Cabral (NIH: National Institutes of Health)H-Index: 26
#2Elena Makareeva (NIH: National Institutes of Health)H-Index: 20
Last. Joan C. Marini (NIH: National Institutes of Health)H-Index: 42
view all 9 authors...
Abstract Patients with OI/EDS form a distinct subset of osteogenesis imperfecta (OI) patients. In addition to skeletal fragility, they have characteristics of Ehlers-Danlos syndrome (EDS). We identified 7 children with types III or IV OI, plus severe large and small joint laxity and early progressive scoliosis. In each child with OI/EDS, we identified a mutation in the first 90 residues of the helical region of α1(I) collagen. These mutations prevent or delay removal of the procollagen N-propept...
82 CitationsSource
#1Anton V. Persikov (UMDNJ: University of Medicine and Dentistry of New Jersey)H-Index: 19
#2John A. M. Ramshaw (UMDNJ: University of Medicine and Dentistry of New Jersey)H-Index: 36
Last. Barbara Brodsky (UMDNJ: University of Medicine and Dentistry of New Jersey)H-Index: 47
view all 3 authors...
Abstract An algorithm was derived to relate the amino acid sequence of a collagen triple helix to its thermal stability. This calculation is based on the triple helical stabilization propensities of individual residues and their intermolecular and intramolecular interactions, as quantitated by melting temperature values of host-guest peptides. Experimental melting temperature values of a number of triple helical peptides of varying length and sequence were successfully predicted by this algorith...
221 CitationsSource
#1Elizabeth G. Canty (Wellcome Trust Centre for Cell-Matrix Research)H-Index: 7
#2Karl E. Kadler (Wellcome Trust Centre for Cell-Matrix Research)H-Index: 49
Collagen fibrils in the extracellular matrix allow connective tissues such as tendon, skin and bone to withstand tensile forces. The fibrils are indeterminate in length, insoluble and form elaborate three-dimensional arrays that extend over numerous cell lengths. Studies of the molecular basis of collagen fibrillogenesis have provided insight into the trafficking of procollagen (the precursor of collagen) through the cellular secretory pathway, the conversion of procollagen to collagen by the pr...
443 CitationsSource
#1Anton V. Persikov (UMDNJ: University of Medicine and Dentistry of New Jersey)H-Index: 19
#2Rian J. Pillitteri (UMDNJ: University of Medicine and Dentistry of New Jersey)H-Index: 1
Last. Barbara Brodsky (UMDNJ: University of Medicine and Dentistry of New Jersey)H-Index: 47
view all 6 authors...
A missense mutation leading to the replacement of one Gly in the (Gly-Xaa-Yaa)n repeat of the collagen triple helix can cause a range of heritable connective tissue disorders that depend on the gene in which the mutation occurs. Osteogenesis imperfecta results from mutations in type I collagen, Ehlers-Danlos syndrome type IV from mutations in type III collagen, Alport syndrome from mutations in type IV collagen, and dystrophic epidermolysis bullosa from mutations in type VII collagen. The predic...
65 CitationsSource
#1Catherine D. Reyes (Georgia Institute of Technology)H-Index: 9
#2Andrés J. García (Georgia Institute of Technology)H-Index: 77
The interactions of osteoblasts with their surrounding extracellular matrix (ECM) are essential for skeletal development, homeostasis, and maintenance of the mature osteoblastic phenotype. Integrins are the principal transducers of ECM signals that regulate this process of osteoblast commitment and differentiation. Several studies indicate that the α2β1 integrin interaction with type I collagen is a crucial signal for the induction of osteoblastic differentiation and matrix mineralization. Integ...
113 CitationsSource
#1Ulrike Schwarze (UW: University of Washington)H-Index: 30
#2Ryu-Ichiro Hata (Kanagawa Dental College)H-Index: 5
Last. Peter H. Byers (UW: University of Washington)H-Index: 70
view all 7 authors...
Splice site mutations in the COL1A2 gene of type I collagen can give rise to forms of Ehlers-Danlos syndrome (EDS) because of partial or complete skipping of exon 6, as well as to mild, moderate, or lethal forms of osteogenesis imperfecta as a consequence of skipping of other exons. We identified three unrelated individuals with a rare recessively inherited form of EDS (characterized by joint hypermobility, skin hyperextensibility, and cardiac valvular defects); in two of them, COL1A2 messenger ...
115 CitationsSource
Abstract Endothelial cell activation involves the elevated expression of cell adhesion molecules, chemoattractants, chemokines, and cytokines. These expression profiles may be regulated by integrin-mediated cell signaling pathways. In the current study, an α2β1 integrin triple helical peptide ligand derived from type I collagen residues α1(I)496–507 was examined for induction of human aortic endothelial cell (HAEC) activation. In addition, a “miniextracellular matrix” composed of a mixture of th...
20 CitationsSource
#1Johan T. den Dunnen (LUMC: Leiden University Medical Center)H-Index: 14
#2Mark H. Paalman (John Wiley & Sons)H-Index: 7
Lydon, April 12, 2008—a XBG patient and his parents sued the department of clinical diagnosis in Lydon, the XBG mutation database, and the journal Human Mutation. The complaint was that serious and culpable mistakes were made during the clinical diagnosis of the pregnancy in the XBGfamily, that ultimately led to the birth of an affected child. A paper published in Human Mutation listed the sequence variant detected in the family as "nonpathogenic." Careful examination would have revealed that th...
176 CitationsSource
Cited By410
Newest
#1Jia Tang (JNU: Jinan University)
Last. Yuping Li
view all 17 authors...
Abstract Background Skeletal dysplasias account for nearly 10% of fetal structural malformations detected by ultrasonography. This clinically heterogeneous group of genetic anomaly includes at least 461 genetic skeletal disorders with extreme clinical, phenotypic, and genetic heterogeneities, thus, significantly complicates accurate diagnosis. Researches have used whole exome sequencing (WES) for prenatal molecular diagnoses of skeletal dysplasias, however, data are still limited. Methods DNA ex...
Source
#1Kristofer Andersson (KI: Karolinska Institutet)H-Index: 2
#2Barbro Malmgren (KI: Karolinska Institutet)H-Index: 25
Last. Göran Dahllöf (KI: Karolinska Institutet)H-Index: 34
view all 6 authors...
BACKGROUND: Osteogenesis imperfecta (OI) is a heterogeneous connective tissue disorder characterized by an increased tendency for fractures throughout life. Autosomal dominant (AD) mutations in COL1A1 and COL1A2 are causative in approximately 85% of cases. In recent years, recessive variants in genes involved in collagen processing have been found. Hypodontia ( /= 6 missing permanent teeth) have previously been reported in individuals with OI. The aim of the present cross-sectional study was to ...
Source
#1Cristina GugH-Index: 2
#2Lavinia Caba (Grigore T. Popa University of Medicine and Pharmacy)H-Index: 3
Last. Gorduza Ev (Grigore T. Popa University of Medicine and Pharmacy)H-Index: 3
view all 7 authors...
Abstract Background Osteogenesis imperfecta (OI) is a rare disease characterized by increased bone fragility and predisposition to fractures, bone deformities and other major signs such as dentinogenesis imperfecta, blue sclera and deafness. Over 90% of OI cases are caused by mutations in the COL1A1 and COL1A2 genes and the inheritance is autosomal dominant. Methods We present a case of a couple requesting genetic counseling, because the man was diagnosed with OI on a clinical and radiological b...
Source
We present the cases of a mother and daughter with osteogenesis imperfecta, also diagnosed later with rheumatoid arthritis. In our patients finding and treating the over-imposed arthritis improved the joint pain initially attributed to osteogenesis imperfecta. Exploring joint inflammation in this setting could help ease the disease burden. PURPOSE: Osteogenesis imperfecta (OI) is a rare hereditary disease evolving with recurrent fractures upon minor trauma, blue sclerae, and hearing loss. Althou...
Source
#1Mingyan Ju (Tianjin Medical University)H-Index: 1
#2Xue BaiH-Index: 1
Last. Guang Li (Tianjin Medical University)H-Index: 8
view all 12 authors...
High-resolution melting (HRM) analysis has been shown to be a time-saving method for the screening of genetic variants. To increase the precision of the diagnosis of osteogenesis imperfecta (OI), we used HRM to explore COL1A1/COL1A2 mutations in 87 Chinese OI patients and to perform population-based studies of the relationships between their genotypes and phenotypes. Peripheral blood samples were collected from the 87 non-consanguineous probands. The coding regions and exon boundaries of COL1A1/...
Source
#1Silvia MorlinoH-Index: 9
#2Lucia Micale (Casa Sollievo della Sofferenza)H-Index: 18
Last. Marco Castori (Casa Sollievo della Sofferenza)H-Index: 5
view all 22 authors...
The 2017 classification of Ehlers‐Danlos syndromes (EDS) identifies three types associated with causative variants in COL1A1/COL1A2 and distinct from osteogenesis imperfecta (OI). Previously, patients have been described with variable features of both disorders, and causative variants in COL1A1/COL1A2; but this phenotype has not been included in the current classification. Here, we expand and re‐define this OI/EDS overlap as a missing EDS type. Twenty‐one individuals from 13 families were report...
Source
#1Wayne A. CabralH-Index: 26
#2Nadja Fratzl-ZelmanH-Index: 27
Last. Paul RoschgerH-Index: 52
view all 17 authors...
Abstract Null mutations in CRTAP or P3H1, encoding cartilage-associated protein and prolyl 3-hydroxylase 1, cause the severe bone dysplasias, types VII and VIII osteogenesis imperfecta. Lack of either protein prevents formation of the ER prolyl 3-hydroxylation complex, which catalyzes 3Hyp modification of types I and II collagen and also acts as a collagen chaperone. To clarify the role of the A1 3Hyp substrate site in recessive bone dysplasia, we generated knock-in mice with an α1(I)P986A subst...
1 CitationsSource
#2Chulaluck KuptanonH-Index: 4
Last. Vorasuk Shotelersuk (Chula: Chulalongkorn University)H-Index: 30
view all 4 authors...
Abstract Osteogenesis imperfecta (OI) is commonly caused by monoallelic mutations in COL1A1 or COL1A2. Biallelic mutations are extremely rare. Only five previous reports have identified seven OI patients with homozygous mutations in COL1A2. OI is a genetically and phenotypically heterogeneous disorder which challenges an establishement of genotype-phenotype correlation. Notably, more than thirty patients with OI possess the heterozygous mutation, p.Gly337Ser, in COL1A2. Their clinical severity r...
Source
#1Silvia Maruelli (UNIPV: University of Pavia)H-Index: 3
#2Roberta Besio (UNIPV: University of Pavia)H-Index: 10
Last. Valérie Trichet (University of Nantes)H-Index: 13
view all 11 authors...
Abstract Classical osteogenesis imperfecta (OI) is an inherited rare brittle bone disease caused by dominant mutations in the COL1A1 or COL1A2 genes, encoding for the α chains of collagen type I. The definitive cure for the disease will require a gene therapy approach, aimed to correct or suppress the mutant allele. Interestingly, individuals lacking α2(I) chain and synthetizing collagen α1(I)3 homotrimers do not show bone phenotype, making appealing a bone specific COL1A2 silencing approach for...
Source
#1Ruibing Li (Chinese PLA General Hospital)H-Index: 1
#1Ruibing Li (Chinese PLA General Hospital)
Last. Chengbin Wang (Chinese PLA General Hospital)H-Index: 1
view all 5 authors...
BACKGROUND: Skeletal disorders, which have great genotypic and phenotypic varieties, are a considerable challenge to differentiate these diseases and provide a definitive prenatal diagnosis or pre-implantation. The present study aims to identify the causative mutation in two unrelated outbred Han-Chinese families. METHOD: Two short-limb fetuses were referred to our hospital. Genomic DNA was extracted from the amniotic fluid of the short-limb fetuses and from peripheral blood of their parents. To...
Source